NL7111160A - - Google Patents
Info
- Publication number
- NL7111160A NL7111160A NL7111160A NL7111160A NL7111160A NL 7111160 A NL7111160 A NL 7111160A NL 7111160 A NL7111160 A NL 7111160A NL 7111160 A NL7111160 A NL 7111160A NL 7111160 A NL7111160 A NL 7111160A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1258771 | 1971-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7111160A true NL7111160A (de) | 1972-09-12 |
Family
ID=11809473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7111160A NL7111160A (de) | 1971-03-09 | 1971-08-13 |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE2154202A1 (de) |
| DK (1) | DK127457B (de) |
| FR (1) | FR2128267A1 (de) |
| NL (1) | NL7111160A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2310580T3 (es) | 1993-04-30 | 2009-01-16 | Wellstat Biologics Corporation | Composiciones purificadas del virus de la enfermedad de newcastle. |
| WO2000003733A1 (en) * | 1998-07-16 | 2000-01-27 | Vincent Marinkovich | Methods and compositions for cancer treatment |
-
1971
- 1971-08-13 NL NL7111160A patent/NL7111160A/xx unknown
- 1971-08-16 FR FR7129864A patent/FR2128267A1/fr active Granted
- 1971-10-30 DE DE19712154202 patent/DE2154202A1/de active Pending
-
1972
- 1972-02-10 DK DK59672AA patent/DK127457B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK127457B (da) | 1973-11-12 |
| FR2128267B1 (de) | 1975-02-07 |
| FR2128267A1 (en) | 1972-10-20 |
| DE2154202A1 (de) | 1972-09-14 |